AdvisorShares launched HVAC & Industrials ETF on Feb. 4, investing in HVAC & industrial companies for long-term growth. Portfolio includes ADRs.

Group behind failed attempt to legalize recreational cannabis in FL has launched new initiative for 2026 ballot. Allows adult use with limits and restrictions.

Amplify ETFs plans to liquidate MJUS, a cannabis-related ETF, due to regulatory issues. Other cannabis ETFs also struggling with DEA's indecisiveness.

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.

MSOS rose over 14% in today’s session. Interestingly, the price action was inside the trading range of Monday. 

Surgeon general warns about alcohol's cancer risk, suggests updates to health labels. Cannabis stocks largely rise while alcohol stocks drop.

In 2024, the cannabis landscape in the U.S. experienced some developments, though federal legalization or removal from the CSA.

For investors, MariMed represents a fundamentally strong outlier, but industry-wide challenges remain a drag on stock performance.

The AdvisorShares Pure US Cannabis ETF (NYSEMSOS), often viewed as a benchmark for MSOs, dropped by -4.31%, closing at $4.56.

Markets opened with a strong tailwind, driven by the latest CPI data showing inflation in line with expectations, bolstering investor confidence.

Donald Trump nominated Rep. Matt Gaetz as attorney general, who has supported cannabis legalization and proposed ending cannabis testing for military recruitment.

Matt Gaetz has been named the attorney general nominee by Donald Trump. The selection comes while Gaetz is being investigated by Congress.

Cannabis stocks rally on prediction of Trump descheduling marijuana; MSOS leads gains with a 15% surge, followed by Cronos at nearly 13%.

What’s promised on the campaign trail and what comes to reality are often different. But that didn’t stop investors and traders from speculating on the most prevalent themes under a new administration. Here's a look at what moved and why.

After a post-election plunge, cannabis stocks are showing signs of recovery. We analyze Tilray, SNDL, Trulieve, MSOS – time to buy the dip?

Following Trump's presidential election victory, the cannabis sector took a sharp downturn. Here's a summary of what happened today.

Cannabis stocks plunge as Florida's legalization fails and GOP Senate control tempers expectations for industry growth.

Florida and the Dakotas reject cannabis measures, while Nebraska approves medical cannabis and Dallas decriminalizes. Explore each state's path forward.

Federal reform and banking access may drive cannabis capital markets in 2025. Discover why upcoming election changes could boost the industry.

Cannabis stocks drop amid broader market downturn and election uncertainty, with major players like Tilray and Aurora Cannabis w/ losses.

AdvisorShares MSOS ETF surges 8% as U.S. cannabis reform nears. Explore key investment signals and market opportunities.

Cannabis leaders at the Benzinga Cannabis Capital Conference see rescheduling and banking reform as game-changers for the industry.

Marijuana companies would be "treated like normal businesses," If the oppressive restrictions of Section 280E of the Internal Revenue Code, which prevents cannabis businesses from deducting typical business expenses, go away.